Department of Psychiatry, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, 52727, Republic of Korea.
Department of Psychiatry, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, 15355, Republic of Korea.
Curr Psychiatry Rep. 2021 Mar 12;23(5):22. doi: 10.1007/s11920-021-01235-x.
We review the association of the microbiota-gut-brain axis and anxiety disorder or stress.
The microbiota-gut-brain axis mechanism encompasses a bidirectional relationship between the brain and gastrointestinal organs. Dysregulation of the microbiota-gut-brain axis has been actively revealed in the context of various psychiatric diseases such as neurodevelopmental disorders, schizophrenia, anxiety disorders, and depression. We suggest that onset of anxiety disorders may be correlated with activation of a microbiota-gut-brain mechanism involving the immune system, neurotransmitters, and the hormonal system. By applying a microbiota-gut-brain axis mechanism, the possibility of using gastrointestinal system drugs such as probiotics and antibiotics as treatments for anxiety disorders is a possibility. Although modification of the microbiota-gut-brain axis mechanism has yet to be adopted clinically, it is expected that novel strategies employing this mechanism will be developed and deployed as new treatments not only for anxiety disorders, but also other psychiatric diseases.
我们综述了肠道菌群-肠-脑轴与焦虑障碍或应激的关系。
肠道菌群-肠-脑轴机制包含了大脑和胃肠道之间的双向关系。在神经发育障碍、精神分裂症、焦虑障碍和抑郁症等各种精神疾病中,肠道菌群-肠-脑轴的失调已被积极揭示。我们提出,焦虑障碍的发作可能与涉及免疫系统、神经递质和激素系统的微生物群-肠-脑机制的激活有关。通过应用肠道菌群-肠-脑轴机制,使用肠道系统药物(如益生菌和抗生素)作为焦虑障碍治疗方法成为可能。虽然肠道菌群-肠-脑轴机制的修饰尚未在临床上采用,但预计将开发和应用该机制的新策略,不仅作为焦虑障碍的新治疗方法,也作为其他精神疾病的新治疗方法。